Idelalisib and Rituximab in Relapsed Chronic Lymphocytic LeukemiaRichard R. Furman, Susan O’Brien, Paolo Ghia et al.|New England Journal of Medicine|2014Cited by 1.7k
Diffuse large B-cell lymphoma: R-CHOP failure—what to do?Bertrand Coiffier, Clémentine Sarkozy|Hematology|2016Cited by 286
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)Michele Ghielmini, Markus Raderer, Umberto Vitolo et al.|Annals of Oncology|2012Cited by 218
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016Christian Dittrich, Rainer Kunstfeld, Michael P. Kosty et al.|ESMO Open|2016Cited by 129
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysisMassimo Federico, Bertrand Coiffier, María Dolores Caballero Barrigón et al.|The Lancet Haematology|2018Cited by 116